Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran
Backgrounds Diabetes is one of the most common metabolic disorders worldwide. This study aim was to provide detail analysis of diabetes research output and its trend in Iran as well as in the world and compare them. Methods Data was retrieved from PubMed database using a suitable search strategy and...
Gespeichert in:
| Veröffentlicht in: | Journal of diabetes and metabolic disorders 2017-02, Vol.16 (1), p.9-9, Article 9 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 9 |
|---|---|
| container_issue | 1 |
| container_start_page | 9 |
| container_title | Journal of diabetes and metabolic disorders |
| container_volume | 16 |
| creator | Nasli-Esfahani, Ensieh Farzadfar, Farshad Kouhnavard, Marjan Ghodssi-Ghassemabadi, Robabeh Khajavi, Alireza Peimani, Maryam Razmandeh, Rezvan Vala, Mahboobeh Shafiee, Gita Rambod, Camelia Sanjari, Mahnaz Aalaa, Maryam Ghodsi, Maryam Razi, Farideh Bandarian, Fatemeh Larijani, Bagher |
| description | Backgrounds
Diabetes is one of the most common metabolic disorders worldwide. This study aim was to provide detail analysis of diabetes research output and its trend in Iran as well as in the world and compare them.
Methods
Data was retrieved from PubMed database using a suitable search strategy and application of proper operator “AND”, “OR” and “NOT”. All English documents published from 2008 to 2012 were included. Meeting abstract, letter to the editor, guidelines, consensus and reviews were excluded. Obtained documents for Iran and world were categorized in eleven groups including diabetes management, education, paediatrics, nutrition, epidemiology, diabetes complications, stem cells, gestational diabetes mellitus (GDM), psychiatrics, genetics and prevention and were compared.
Results
Total number of DM publications was 59513 for world and 648 for Iran. Trend of DM publications was increasing during the 5 years with a growth rate of 22.5% for world and 23.4% for Iran. Contribution of Iran in the world diabetes output reached 1.08 in 2012. The most and the least number of DM documents were related to complications and preventions, respectively both in Iran and the world. Three leading countries with highest proportion of RCTs (randomized clinical trial) to their total DM publications were Italy, Germany and Iran.
Conclusion
The most number of diabetes research was in the field of diabetes complication, management and genetics in the world as well as in Iran. During the 5-year period, despite of the world sanctions against Iran, diabetes research trend was increasing in Iran relatively parallel to the world research and sanction had no significant effect on Iran. |
| doi_str_mv | 10.1186/s40200-017-0291-9 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5316224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A481663504</galeid><sourcerecordid>A481663504</sourcerecordid><originalsourceid>FETCH-LOGICAL-c568t-5edb1fa0525c7bfc22e8f5643416685a10865b5ddba7361b19a1e6b96caedf9c3</originalsourceid><addsrcrecordid>eNp1kt1v1SAYxhujccvcH-CNITEx86ITaKHgxZJl8-MkS0wWvSYU3p7DbOEIrWb__aid8xwz4QICv-d5-XiK4iXBp4QI_i7VmGJcYtKUmEpSyifFIaWMlJwJ8nRnflAcp3SDc2saIQh_XhxQQSvJpDwsvq-i9sg63cIICUVIoKPZoBi0HfQWnawur6_fojRO9vY90mgboXeD8zreLosoPCZ3Ho0bQL9C7C3S3qK5zIviWaf7BMf341Hx7eOHrxefy6svn1YX51elYVyMJQPbkk5jRplp2s5QCqJjvK5qwrlgmmDBWcusbXVTcdISqQnwVnKjwXbSVEfF2eK7ndoBrAE_Rt2rbXRDPrYK2qn9He82ah1-KlYRTmmdDU7uDWL4MUEa1eCSgb7XHsKUFBENZYI2eEZf_4PehCn6fL2ZqklVyUr8pda6B-V8F3JdM5uq8zp_Ca_Yb6_TR6jcLQzOBA-dy-t7gjc7gg3oftyk0E-jCz7tg2QBTQwpRegeHoNgNadJLWlSOU1qTpOSWfNq9xUfFH-ykwG6AClv-TXEnav_1_UOpMTS8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1874133938</pqid></control><display><type>article</type><title>Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran</title><source>SpringerLink Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Nasli-Esfahani, Ensieh ; Farzadfar, Farshad ; Kouhnavard, Marjan ; Ghodssi-Ghassemabadi, Robabeh ; Khajavi, Alireza ; Peimani, Maryam ; Razmandeh, Rezvan ; Vala, Mahboobeh ; Shafiee, Gita ; Rambod, Camelia ; Sanjari, Mahnaz ; Aalaa, Maryam ; Ghodsi, Maryam ; Razi, Farideh ; Bandarian, Fatemeh ; Larijani, Bagher</creator><creatorcontrib>Nasli-Esfahani, Ensieh ; Farzadfar, Farshad ; Kouhnavard, Marjan ; Ghodssi-Ghassemabadi, Robabeh ; Khajavi, Alireza ; Peimani, Maryam ; Razmandeh, Rezvan ; Vala, Mahboobeh ; Shafiee, Gita ; Rambod, Camelia ; Sanjari, Mahnaz ; Aalaa, Maryam ; Ghodsi, Maryam ; Razi, Farideh ; Bandarian, Fatemeh ; Larijani, Bagher</creatorcontrib><description>Backgrounds
Diabetes is one of the most common metabolic disorders worldwide. This study aim was to provide detail analysis of diabetes research output and its trend in Iran as well as in the world and compare them.
Methods
Data was retrieved from PubMed database using a suitable search strategy and application of proper operator “AND”, “OR” and “NOT”. All English documents published from 2008 to 2012 were included. Meeting abstract, letter to the editor, guidelines, consensus and reviews were excluded. Obtained documents for Iran and world were categorized in eleven groups including diabetes management, education, paediatrics, nutrition, epidemiology, diabetes complications, stem cells, gestational diabetes mellitus (GDM), psychiatrics, genetics and prevention and were compared.
Results
Total number of DM publications was 59513 for world and 648 for Iran. Trend of DM publications was increasing during the 5 years with a growth rate of 22.5% for world and 23.4% for Iran. Contribution of Iran in the world diabetes output reached 1.08 in 2012. The most and the least number of DM documents were related to complications and preventions, respectively both in Iran and the world. Three leading countries with highest proportion of RCTs (randomized clinical trial) to their total DM publications were Italy, Germany and Iran.
Conclusion
The most number of diabetes research was in the field of diabetes complication, management and genetics in the world as well as in Iran. During the 5-year period, despite of the world sanctions against Iran, diabetes research trend was increasing in Iran relatively parallel to the world research and sanction had no significant effect on Iran.</description><identifier>ISSN: 2251-6581</identifier><identifier>EISSN: 2251-6581</identifier><identifier>DOI: 10.1186/s40200-017-0291-9</identifier><identifier>PMID: 28239599</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Bibliometrics ; Collaboration ; Data collection ; Diabetes ; Diabetes mellitus ; Distribution ; Endocrinology ; Expenditures ; Funding ; Health promotion ; Kidney diseases ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Metabolism ; Methods ; Physicians ; Prevalence studies (Epidemiology) ; Quality ; Review ; Review Article</subject><ispartof>Journal of diabetes and metabolic disorders, 2017-02, Vol.16 (1), p.9-9, Article 9</ispartof><rights>The Author(s). 2017</rights><rights>COPYRIGHT 2017 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c568t-5edb1fa0525c7bfc22e8f5643416685a10865b5ddba7361b19a1e6b96caedf9c3</citedby><cites>FETCH-LOGICAL-c568t-5edb1fa0525c7bfc22e8f5643416685a10865b5ddba7361b19a1e6b96caedf9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316224/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316224/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,41469,42538,51300,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28239599$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nasli-Esfahani, Ensieh</creatorcontrib><creatorcontrib>Farzadfar, Farshad</creatorcontrib><creatorcontrib>Kouhnavard, Marjan</creatorcontrib><creatorcontrib>Ghodssi-Ghassemabadi, Robabeh</creatorcontrib><creatorcontrib>Khajavi, Alireza</creatorcontrib><creatorcontrib>Peimani, Maryam</creatorcontrib><creatorcontrib>Razmandeh, Rezvan</creatorcontrib><creatorcontrib>Vala, Mahboobeh</creatorcontrib><creatorcontrib>Shafiee, Gita</creatorcontrib><creatorcontrib>Rambod, Camelia</creatorcontrib><creatorcontrib>Sanjari, Mahnaz</creatorcontrib><creatorcontrib>Aalaa, Maryam</creatorcontrib><creatorcontrib>Ghodsi, Maryam</creatorcontrib><creatorcontrib>Razi, Farideh</creatorcontrib><creatorcontrib>Bandarian, Fatemeh</creatorcontrib><creatorcontrib>Larijani, Bagher</creatorcontrib><title>Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran</title><title>Journal of diabetes and metabolic disorders</title><addtitle>J Diabetes Metab Disord</addtitle><addtitle>J Diabetes Metab Disord</addtitle><description>Backgrounds
Diabetes is one of the most common metabolic disorders worldwide. This study aim was to provide detail analysis of diabetes research output and its trend in Iran as well as in the world and compare them.
Methods
Data was retrieved from PubMed database using a suitable search strategy and application of proper operator “AND”, “OR” and “NOT”. All English documents published from 2008 to 2012 were included. Meeting abstract, letter to the editor, guidelines, consensus and reviews were excluded. Obtained documents for Iran and world were categorized in eleven groups including diabetes management, education, paediatrics, nutrition, epidemiology, diabetes complications, stem cells, gestational diabetes mellitus (GDM), psychiatrics, genetics and prevention and were compared.
Results
Total number of DM publications was 59513 for world and 648 for Iran. Trend of DM publications was increasing during the 5 years with a growth rate of 22.5% for world and 23.4% for Iran. Contribution of Iran in the world diabetes output reached 1.08 in 2012. The most and the least number of DM documents were related to complications and preventions, respectively both in Iran and the world. Three leading countries with highest proportion of RCTs (randomized clinical trial) to their total DM publications were Italy, Germany and Iran.
Conclusion
The most number of diabetes research was in the field of diabetes complication, management and genetics in the world as well as in Iran. During the 5-year period, despite of the world sanctions against Iran, diabetes research trend was increasing in Iran relatively parallel to the world research and sanction had no significant effect on Iran.</description><subject>Bibliometrics</subject><subject>Collaboration</subject><subject>Data collection</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Distribution</subject><subject>Endocrinology</subject><subject>Expenditures</subject><subject>Funding</subject><subject>Health promotion</subject><subject>Kidney diseases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Metabolism</subject><subject>Methods</subject><subject>Physicians</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Quality</subject><subject>Review</subject><subject>Review Article</subject><issn>2251-6581</issn><issn>2251-6581</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kt1v1SAYxhujccvcH-CNITEx86ITaKHgxZJl8-MkS0wWvSYU3p7DbOEIrWb__aid8xwz4QICv-d5-XiK4iXBp4QI_i7VmGJcYtKUmEpSyifFIaWMlJwJ8nRnflAcp3SDc2saIQh_XhxQQSvJpDwsvq-i9sg63cIICUVIoKPZoBi0HfQWnawur6_fojRO9vY90mgboXeD8zreLosoPCZ3Ho0bQL9C7C3S3qK5zIviWaf7BMf341Hx7eOHrxefy6svn1YX51elYVyMJQPbkk5jRplp2s5QCqJjvK5qwrlgmmDBWcusbXVTcdISqQnwVnKjwXbSVEfF2eK7ndoBrAE_Rt2rbXRDPrYK2qn9He82ah1-KlYRTmmdDU7uDWL4MUEa1eCSgb7XHsKUFBENZYI2eEZf_4PehCn6fL2ZqklVyUr8pda6B-V8F3JdM5uq8zp_Ca_Yb6_TR6jcLQzOBA-dy-t7gjc7gg3oftyk0E-jCz7tg2QBTQwpRegeHoNgNadJLWlSOU1qTpOSWfNq9xUfFH-ykwG6AClv-TXEnav_1_UOpMTS8g</recordid><startdate>20170217</startdate><enddate>20170217</enddate><creator>Nasli-Esfahani, Ensieh</creator><creator>Farzadfar, Farshad</creator><creator>Kouhnavard, Marjan</creator><creator>Ghodssi-Ghassemabadi, Robabeh</creator><creator>Khajavi, Alireza</creator><creator>Peimani, Maryam</creator><creator>Razmandeh, Rezvan</creator><creator>Vala, Mahboobeh</creator><creator>Shafiee, Gita</creator><creator>Rambod, Camelia</creator><creator>Sanjari, Mahnaz</creator><creator>Aalaa, Maryam</creator><creator>Ghodsi, Maryam</creator><creator>Razi, Farideh</creator><creator>Bandarian, Fatemeh</creator><creator>Larijani, Bagher</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170217</creationdate><title>Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran</title><author>Nasli-Esfahani, Ensieh ; Farzadfar, Farshad ; Kouhnavard, Marjan ; Ghodssi-Ghassemabadi, Robabeh ; Khajavi, Alireza ; Peimani, Maryam ; Razmandeh, Rezvan ; Vala, Mahboobeh ; Shafiee, Gita ; Rambod, Camelia ; Sanjari, Mahnaz ; Aalaa, Maryam ; Ghodsi, Maryam ; Razi, Farideh ; Bandarian, Fatemeh ; Larijani, Bagher</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c568t-5edb1fa0525c7bfc22e8f5643416685a10865b5ddba7361b19a1e6b96caedf9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Bibliometrics</topic><topic>Collaboration</topic><topic>Data collection</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Distribution</topic><topic>Endocrinology</topic><topic>Expenditures</topic><topic>Funding</topic><topic>Health promotion</topic><topic>Kidney diseases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Metabolism</topic><topic>Methods</topic><topic>Physicians</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Quality</topic><topic>Review</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nasli-Esfahani, Ensieh</creatorcontrib><creatorcontrib>Farzadfar, Farshad</creatorcontrib><creatorcontrib>Kouhnavard, Marjan</creatorcontrib><creatorcontrib>Ghodssi-Ghassemabadi, Robabeh</creatorcontrib><creatorcontrib>Khajavi, Alireza</creatorcontrib><creatorcontrib>Peimani, Maryam</creatorcontrib><creatorcontrib>Razmandeh, Rezvan</creatorcontrib><creatorcontrib>Vala, Mahboobeh</creatorcontrib><creatorcontrib>Shafiee, Gita</creatorcontrib><creatorcontrib>Rambod, Camelia</creatorcontrib><creatorcontrib>Sanjari, Mahnaz</creatorcontrib><creatorcontrib>Aalaa, Maryam</creatorcontrib><creatorcontrib>Ghodsi, Maryam</creatorcontrib><creatorcontrib>Razi, Farideh</creatorcontrib><creatorcontrib>Bandarian, Fatemeh</creatorcontrib><creatorcontrib>Larijani, Bagher</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes and metabolic disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nasli-Esfahani, Ensieh</au><au>Farzadfar, Farshad</au><au>Kouhnavard, Marjan</au><au>Ghodssi-Ghassemabadi, Robabeh</au><au>Khajavi, Alireza</au><au>Peimani, Maryam</au><au>Razmandeh, Rezvan</au><au>Vala, Mahboobeh</au><au>Shafiee, Gita</au><au>Rambod, Camelia</au><au>Sanjari, Mahnaz</au><au>Aalaa, Maryam</au><au>Ghodsi, Maryam</au><au>Razi, Farideh</au><au>Bandarian, Fatemeh</au><au>Larijani, Bagher</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran</atitle><jtitle>Journal of diabetes and metabolic disorders</jtitle><stitle>J Diabetes Metab Disord</stitle><addtitle>J Diabetes Metab Disord</addtitle><date>2017-02-17</date><risdate>2017</risdate><volume>16</volume><issue>1</issue><spage>9</spage><epage>9</epage><pages>9-9</pages><artnum>9</artnum><issn>2251-6581</issn><eissn>2251-6581</eissn><abstract>Backgrounds
Diabetes is one of the most common metabolic disorders worldwide. This study aim was to provide detail analysis of diabetes research output and its trend in Iran as well as in the world and compare them.
Methods
Data was retrieved from PubMed database using a suitable search strategy and application of proper operator “AND”, “OR” and “NOT”. All English documents published from 2008 to 2012 were included. Meeting abstract, letter to the editor, guidelines, consensus and reviews were excluded. Obtained documents for Iran and world were categorized in eleven groups including diabetes management, education, paediatrics, nutrition, epidemiology, diabetes complications, stem cells, gestational diabetes mellitus (GDM), psychiatrics, genetics and prevention and were compared.
Results
Total number of DM publications was 59513 for world and 648 for Iran. Trend of DM publications was increasing during the 5 years with a growth rate of 22.5% for world and 23.4% for Iran. Contribution of Iran in the world diabetes output reached 1.08 in 2012. The most and the least number of DM documents were related to complications and preventions, respectively both in Iran and the world. Three leading countries with highest proportion of RCTs (randomized clinical trial) to their total DM publications were Italy, Germany and Iran.
Conclusion
The most number of diabetes research was in the field of diabetes complication, management and genetics in the world as well as in Iran. During the 5-year period, despite of the world sanctions against Iran, diabetes research trend was increasing in Iran relatively parallel to the world research and sanction had no significant effect on Iran.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>28239599</pmid><doi>10.1186/s40200-017-0291-9</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2251-6581 |
| ispartof | Journal of diabetes and metabolic disorders, 2017-02, Vol.16 (1), p.9-9, Article 9 |
| issn | 2251-6581 2251-6581 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5316224 |
| source | SpringerLink Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Bibliometrics Collaboration Data collection Diabetes Diabetes mellitus Distribution Endocrinology Expenditures Funding Health promotion Kidney diseases Medicine Medicine & Public Health Metabolic Diseases Metabolism Methods Physicians Prevalence studies (Epidemiology) Quality Review Review Article |
| title | Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A30%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Iran%20diabetes%20research%20roadmap%20(IDRR)%20study:%20a%20preliminary%20study%20on%20diabetes%20research%20in%20the%20world%20and%20Iran&rft.jtitle=Journal%20of%20diabetes%20and%20metabolic%20disorders&rft.au=Nasli-Esfahani,%20Ensieh&rft.date=2017-02-17&rft.volume=16&rft.issue=1&rft.spage=9&rft.epage=9&rft.pages=9-9&rft.artnum=9&rft.issn=2251-6581&rft.eissn=2251-6581&rft_id=info:doi/10.1186/s40200-017-0291-9&rft_dat=%3Cgale_pubme%3EA481663504%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1874133938&rft_id=info:pmid/28239599&rft_galeid=A481663504&rfr_iscdi=true |